Erythema Toxicum Neonatorum (ETN)
Benign Transient Neonatal Pustular Dermatosis
Primary risk age: Neonates (Typically presents within 24 to 72 hours of birth; rare in premature infants)
- Urgency
- Mild
- Typical age
- Neonates (Typically presents within 24 to 72 hours of birth; rare in premature infants)
- Body system
- Dermatological System
Typical course: Spontaneous resolution occurs within 5 to 10 days of onset.
Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13
1. Summary & Pathophysiology
Benign Transient Neonatal Pustular Dermatosis
Pathophysiology (Development Path)
A benign accumulation of eosinophils around the pilosebaceous units (hair follicles) in the dermis. The lesions are inflammatory but do not contain bacteria, representing a sterile immune reaction.
Primary Causes & Etiology
Idiopathic etiology; believed to represent a transient inflammatory response as the newborn skin adapts to the external environment and bacterial colonization.
2. Symptom Continuum
- Early Onset Signs
Small, pinpoint papules or pustules (1 to 3 mm) appearing on a surrounding blotchy, red (erythematous) base.
- Progressive Phase
Multiple separate blotches spreading across the trunk, face, and proximal extremities. The palms of the hands and soles of the feet are spared (as they lack hair follicles).
- Severe Indicators
While visually dramatic, the condition is completely benign and asymptomatic. The infant remains active, feeds well, has no fever, and exhibits no systemic distress.
3. Clinical Verification
Clinical diagnosis based on the classic appearance and timing. If diagnostic doubt exists, a smear of a pustule will show numerous eosinophils and an absence of bacteria.
4. Care & Elements Plan
Primary Care Treatment Plan
Reassurance of the parents. No medical treatment is indicated, as the rash resolves spontaneously without scarring.
Home Support Elements
Avoid squeezing, popping, or scrubbing the pustules. Keep the newborn's skin clean and dry. Avoid applying harsh oils or ointments to the rash.
Generic Active Ingredients (No Brands)
- None. This is a self-limiting, benign physiological skin reaction requiring no active drug therapy.
Lists active elements only. Never administer self-designed therapies.
5. Doctor Critical Lines
Critical Thresholds: When to See a Doctor
Consult a pediatrician if the rash is accompanied by a fever, lethargy, poor feeding, or if the pustules spread to the palms or soles (which may indicate neonatal herpes).
6. Vaccine & Prevention
Routine Prophylaxis (Prevention)
No preventative measures exist, as this is a normal newborn skin reaction.
Immunization Context
No specific immunizations are associated with this benign skin rash.
7. Timelines & Outlook
Active Timeline
Spontaneous resolution occurs within 5 to 10 days of onset.
Expected Prognosis
Excellent. The rash resolves completely without scarring or long-term skin sensitivity.
Potential Untreated Complications
No complications occur. Anxiety in parents is the primary concern.
More in Atopic & Hypersensitivity Epidermal Barriers
Mild Atopic Dermatitis (Infantile Eczema)
Chronic Relapsing Pruritic Inflammatory Skin Disease
Infants starting at 2 to 6 months through childhood and adolescence.
Mild Pityriasis Rosea
Benign Self-Limiting Post-Viral Exanthem
5 to 15 Years (Peak occurrence)
Mild Diaper Dermatitis (Diaper Rash)
Common irritant or fungal inflammation of the skin in the diaper area.
Infants and toddlers in diapers, most common at 9–12 months.